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Abstract
Introduction Bone strength describes the resistance of
bone against mechanical failure. Bone strength depends on
both the amount of bone and the bone’s quality, and the
bone strength may be looked upon as a relevant parameter
to judge an osteosynthesis’ stability. Information about bone
strength was barely available intraoperatively in the past.
The previous work of our group reported on development
and laboratory evaluation of mechanical torque measure-
ment as a method for the intraoperative quantiWcation of
bone strength. With the clinical series presented here we
intend to verify that the im gesamten Text DensiProbe™
instrumentation for intraoperative torque measurement and
the related measurement method are eligible for intraopera-
tive use based on the following criteria: application of the
method may not create complications, the measurement can
be performed by the surgeon himself and may only cause a
limited increase in the procedure time.
Patients and methods From December 2006 until May
2007 ten patients with a pertrochanteric femoral fracture or
a lateral femoral neck fracture eligible for stabilization with
DHS® were included in the study after having received
informed consent. Any medication and comorbidity that
might have inXuenced bone quality or bone mineral density
(BMD) in these patients was documented. Bone strength
was intraoperatively measured with DensiProbe®. Compli-
cations that were obviously related with torque measure-
ment were documented as well as any deviation from the
suggested procedure; 6 and 12 weeks postoperative follow-
up included clinical and radiological examination. The time
required for torque measurement, the overall operating time
and the number of persons present in the operating room
were protocolled. BMD values of the contralateral femoral
neck were postoperatively assessed by dual energy X-ray
absorptiometry (DEXA) and compared to intraoperative
peak torque values measured by DensiProbe®.
Results No major complication was observed during
intraoperative application of DensiProbe®by trained sur-
geons. The unintended extraction of the guide wire together
with the torque measurement probe was reported only once
and is looked upon as a minor complication. Fracture heal-
ing was uneventful in all patients. The mean time for torque
measurement was 2.35 § 0.9 min accounting for
2.2 § 1.1% of total surgery time. The presence of an addi-
tional person was not required to perform torque measure-
ment but to protocol the data. There was a tendency
towards correlation between BMD values of the femoral
neck and intraoperative peak torque values.
Discussion The data presented clearly indicate that the
DensiProbe® instrumentation and measurement principle
are eligible for routine intraoperative use by trained sur-
geons. Interpretation of possible correlations between BMD
values measured by means of DEXA and the Peak Torque
values assessed by DensiProbe® has to be considered very
carefully, because BMD and Peak Torque analyse bone at a
diVerent scale. Only within the framework of a multicenter
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614 Arch Orthop Trauma Surg (2008) 128:613–620study it will be possible to include a suYcient number of
patients for calculation of the methods’ predictive value
towards implant failure and to verify acceptance of the
method by the surgeons.
Keywords Bone strength · Proximal femoral fracture · 
Bone mineral density · Bone densitometry
Introduction 
Proper use of implants and augmentation techniques [1–12]
dedicated for fracture Wxation in osteoporotic bone follows
previous estimation of an osteosynthesis’ stability. Several
parameters inXuence the overall osteosynthesis’ stability,
such as fracture type, quality of fracture reduction [13],
implant position [14, 15] and bone strength [16]. All
parameters, except for the bone strength, can be rated pre-
operatively or intraoperatively by the surgeon.
Bone strength, however, depends on the structural and
material properties of bone [16, 17]. In the past there was
no measurement principle or instrumentation available in
the market for the intraoperative quantiWcation of bone
strength. Instead, bone strength is indirectly estimated by
bone mineral density (BMD) using dual-energy X-ray
absorptiometry (DEXA). Since DEXA-measured BMD
accounts for only 60–70% of the variation in bone strength,
some important factors are not captured by DEXA. More-
over, DEXA measurement is not routinely available preop-
eratively or intraoperatively [18] but can clearly be
performed “noninvasively”. DEXA measurements might
therefore help to estimate the fracture risk of a patient, to
put the diagnosis of osteoporosis and to indicate or to mon-
itor an antiresorptive drug therapy of osteoporosis.
On the other hand the assessment of intrinsic mechanical
quality of bony tissue should provide a better estimation of
bone strength [17]. This option might come into play in
patients who have suVered from a fracture and where the sur-
geon plans to perform osteosynthesis. While performing sur-
gery, the surgeon gets direct access to the bone. Previous
work from our group [19] describes development and labora-
tory evaluation of a new method for intraoperative measure-
ment of bone strength. The torque to breakaway of trabecular
bone is measured with the DensiProbe® instrumentation. This
should provide immediate and more accurate information
about bone strength than the postoperative DEXA scan could.
The dimensions and the application scheme of DensiProbe®
are adapted for the use with the standard DHS® implant.
Requirements
Intraoperative application of DensiProbe® instrumentation
requires perfect compliance with the hygienic standards in
the operating theatre. Furthermore there should be minimal
potential for complications due to the intraoperative mea-
surement of bone strength. The surgeon should be able to
perform the measurement independently on his own, and
the extra time needed for the measurement should be mini-
mal when compared to the overall length of the procedure.
With the pilot series presented here we intended to verify
the following hypothesis:
• The DensiProbe® instrumentation is eligible for intraop-
erative use based on the criteria mentioned above.
Within our stepwise approach to introduce the intraopera-
tive measurement of bone strength into clinical routine, this
would mean clariWcation of the method for evaluation
within a multicenter trial.
Materials and methods
Enrollment of patients
Following protocol approval by the local ethical committee,
patients with proximal femoral fractures having given their
informed consent were enrolled in the study from Decem-
ber 2006 until May 2007. The inclusion criteria were
deWned as the presence of either a stable or unstable pertro-
chanteric femoral fracture (classiWed according to AO as
31A1–A3) [20] or a lateral femoral neck fracture (classiWed
according to Garden as type 1–4) [21] eligible for stabiliza-
tion with DHS®. The lower age limit for inclusion was 35,
in order to assure a wide spectrum of bone qualities was
measured during the study. Exclusion criteria were pre-
existing local infections of the aVected hip and pathologic
fractures due to primary malignancies or metastatic lesions
in the proximal femur. Upon inclusion in the study, all
patients were screened for conditions potentially impairing
bone strength such as previous surgery in the proximal
femur and the presence of major and minor risk factors for
osteoporosis (i.e., personal or familiar history of fragility
fractures, presence of osteoporotic vertebral fractures, treat-
ment with steroids and anticonvulsants, malabsorption
syndrome, physical inactivity, cigarette smoking, low body
weight and advanced age). Moreover intake of basic osteo-
porosis prophylaxis (calcium plus vitamin D) or speciWc
antiosteoporotic therapy (bisphosphonates, SERM, parat-
hormon) was recorded.
Mechanical torque measurement 
Bone strength was measured according to our recently
described measurement principle [19], which is fully
adapted to stabilization of proximal femoral fracture using
the DHS® implant. Fracture reduction and exposure were123
Arch Orthop Trauma Surg (2008) 128:613–620 615done according to the guidelines for DHS® insertion. Under
Xuoroscopic control, a K-wire for subsequent guided inser-
tion of the DHS® screw was drilled in the subchondral bone
of the femoral head reaching a central-to-inferior position
in the AP view and a central-to-posterior position in the
axial view. The length of this guide was measured. A sec-
ond K-wire was inserted in parallel but cranially to the Wrst
one in order to prevent rotation of the head-neck fragment
during subsequent torque measurement and insertion of the
DHS® screw (Fig. 1a, b). Using the 8.0 mm cannulated spi-
ral drill guided by the lower K-wire, the lateral cortex of the
femur was opened. As an adaptation to the standard tech-
nique, the spiral drill was inserted to a depth 45 mm less
than the subchondral bone in order to avoid removal of tra-
becular bone at the site of the following measurement pro-
cedure (Fig. 2a, b). After removal of the spiral drill, a
custom-made cannulated mechanical probe was inserted
over the pre-positioned guide wire into the femoral head.
Measurement of bone strength happened at the tip of the
rod-like mechanical probe. The tip consists of a wing blade
with 6.5 mm outer diameter and 20.0 mm blade length
(Fig. 3). To position this wing blade at the intended site of
the DHS® screw tip at a depth 15 mm less than the guide
wire length, a few gentle hammer blows were applied
(Fig. 4a). A scale at the tail of the probe veriWed the correct
insertion depth of the probe (Fig. 4b). The Wnal position of
the measurement probe was documented by Xuoroscopy
(Fig. 4c). Then, a handhold with an intrinsic calibrated dig-
ital torque meter (AO Development, Davos, Switzerland)
was locked at the lateral end of the probe, which was subse-
quently rotated around its longitudinal axis (Fig. 5a). The
peak torque until complete breakaway of the cancellous
bone between the wings of the mechanical probe was
recorded by the digital torque meter located in the handhold
(Fig. 5b). The digital meter registered the torque values in
the range from 1 to 8 Nm. A minimal torque of 1 Nm has to
be applied in order to trigger the measurement process.
This lower limit was chosen in order to prevent the unin-
tended activation of torque recording. If the torque neces-
sary to break away the cancellous bone exceeded 8 Nm,
the system would unlock allowing free rotation to prevent
rotation of the head and neck fragment. The data were pro-
cessed with MATLAB Software (The MathWorks, Massa-
chusetts, USA). The surgeon performing the measurement
procedure was blinded to the result. Then the probe was
removed and the cannulated spiral drill was reinserted over
the guide wire still in place. The drilling was then com-
pleted to a depth 10 mm less then the subchondral bone as
described in the standard operation procedure for DHS®
implantation. The subsequent procedure of DHS® implan-
tation was completed without further adaptations. For each
patient, the time needed for insertion of the measurement
Fig. 1 a, b Under Xuoroscopic 
control a guide wire is inserted 
to reach the subchondral bone of 
the femoral head. A second 
guide wire is drilled in cranially 
to prevent rotation of the head 
neck fragment during subse-
quent DHS® implantation. The 
length of the guide wire is 
measured
Fig. 2 a, b Reduced pertro-
chanteric fracture with the guide 
wire and second cranially placed 
k-wire to prevent rotation pin in 
place. The canulated spiral drill 
is inserted to a depth 45 mm less 
than the guide wire123
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the removal of the measurement blade were recorded and
related to the total surgery time from skin incision to skin
closure.
Complications
Penetration of the guide wire into the pelvis during inser-
tion of the blade, secondary loss of fracture reduction,
wound infection or delayed fracture healing were the worst
complications that could be imagined owing to the intraop-
erative use of DensiProbe®. Preventive measures were
taken as a result of a risk management process. However,
these events may not be prevented in all situations by the
measurements taken and they were therefore carefully
monitored during the pilot series. Extraction of the guide
wire with the blade was also expected, but was looked upon
as a minor complication. Moreover, any deviation of the
intraoperative procedure from the intended scheme of
application described above was documented and analyzed
for the potential of a complication.
BMD measurement and postoperative follow-up
Fracture reduction and screw position was recorded on
plain radiographs in all patients prior to mobilization under
full weight bearing. Patients were then clinically and radio-
graphically followed up at 6 and 12 weeks following sur-
gery for presence of postoperative infection, fracture union,
screw loosening or cut out. In the course of postoperative
rehabilitation, all patients underwent standard dual energy
X-ray absorptiometry (DEXA) to measure BMD of the
spine as well as the femoral neck, intertrochanteric and tro-
chanteric area of contralateral unfractured proximal femur.
The presence of the implant impaired measurement of the
fractured side. But because there is tight correlation
between the BMD values of both the proximal femurs,
hence [22] BMD measurement at the contralateral unfrac-
tured side is justiWed. The BMD values of the femoral neck
were then compared to intraoperatively recorded peak
torque values.
Fig. 3 The cannulated rod like mechanical probe: Central cannulation
allows insertion over the guide wire. The tip consists of three blades
placed at an angular distance at 120° each. A measurement scale at the
tail allows control of the insertion depth of the probe
Fig. 4 The cannulated probe is inserted over the guide wire to reach
the site of the intended DHS® tip (a). The scale at the tail of the probe
ensures control of insertion depth (b). The Wnal position of the probe is
documented (c)123
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Patient population
In the inclusion period, 10 patients (six females, four males,
mean age: 57 § 16 years) with four pertrochanteric frac-
tures (three, AO31A1; one, AO31A2) and six lateral femo-
ral neck fractures (two Garden 1; three Garden 2; one
Garden 4) were enrolled in the study. Six fractures were
located on the left side and four fractures on the right side.
Table 1 lists all 10 patients with demographic data, type
and cause of fracture and presence of BMD modifying
conditions.
Seven fractures were caused by a minor trauma, whereas
three fractures were the result of an intermediate trauma
(fall from a bike, severe direct trauma to the hip during a
Wght). Four patients reported previous fragility fractures,
but no patient indicated familiar burden for such a fracture.
Vertebral compression fractures were detected on the chest
X-ray in two patients.
Three patients exhibited long-term medication with
systemic steroids. Of these, two patients suVered from auto-
immune disease (myasthenia gravis and colitis ulcerosa
respectively) and one had a history of bone marrow trans-
plantation due to acute myeloic leukemia. Another two
patients indicated regular treatment with topical steroids
because of asthma. One patient reported regular intake of
anticonvulsants in the context of hereditary epilepsia. Three
patients were heavy smokers (>20 PY) and another three
patients exhibited a BMI lower than 18 kg/m2. Treatment
with calcium/vitamin D had been installed in one patient
and no patient was on bisphosphonates.
Peak torque measurement
No major complication occurred during intraoperative
torque measurement. In one case, the guide wire for screw
insertion was accidentally pulled out when the cannulated
probe was removed from the femoral head. Reinsertion of
the guide wire was not problematic. No loss of previously
achieved fracture reduction or iatrogenic fracture occurred
during the measurement procedures. In the postoperative
period, none of the patients showed clinical signs of a sur-
gical site infection. Moreover, fracture healing was
uneventful in all the patients. All the fractures united within
three months. No screw loosening or cut out was recorded.
Table 1 Short characterization of each patient included in the study.
The cause of fracture is abbreviated by numbers with 1 corresponding
to a low energy trauma such as falling from a standing position and 2
corresponding to an intermediate trauma such as falling from a bicycle








1 40/Female Garden 2 1 Topical steroids (asthma)
2 76/Female AO31A1 1 Vertebral fracture, BMI 15.3 kg/m2
3 63/Female Garden 2 2 Systemic steroids after bone marrow transplantation 
due to acute myeloic leucemia, treatment with calcium vitamine D
4 65/Male A031A1 2 Systemic steroids due to colitis ulcerosa.
5 77/Female A031A1 1 Vertebral fracture, smoking (77 pack years), BMI 16.9 kg/m2
6 35/Male Garden 1 2 Treatment with anticonvulsants
7 70/Female Garden 2 1 None detected
8 66/Male A031A2 1 Topical steroids (asthma)
9 39/Female Garden 4 1 Systemic steroids due to myasthenia gravis
10 40/Male Garden 1 1 Smoking (22 pack years)
Fig. 5 a, b The handhold with 
its intrinsic digital torque meter 
is mounted and the probe is 
rotated along its longitudinal 
axis. Peak torque to breakaway 
cancellous bone is registered by 
the digital torque meter in the 
handhold123
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surgeons never required the presence of any additional per-
son except for data protocol.
The mean time for torque measurement was 2.35 §
0.9 min accounting for 2.2 § 1.1% of total surgery time. The
peak torque as recorded by the digital torque meter ranged
from 1.2 to 7.8 Nm with a mean of 3.8 § 2.3 Nm.
BMD measurement by dual energy X-ray absorptiometry 
and postoperative follow-up
Postoperative DEXA scans were performed in all but one
(patient number seven) who refused investigation of bone
mineral density despite previous acceptance with the study
protocol. However, this patient received a standard radio-
graphic follow-up.
The mean BMD values of the spine were 0.822 § 0.12 g/
cm2. One patient showed normal BMD values of the spine.
Osteoporotic (t value <¡2.5) and osteopenic spine BMD
values (t value between ¡1 and ¡2.5) were detected in four
patients, respectively. The mean BMD values of the femoral
neck were 0.694 § 0.187 g/cm2. In detail, the BMD values
at the femoral neck qualiWed for osteoporosis in four
patients, osteopenia in three patients and normal values in
two patients. Overall, seven patients were diagnosed with
osteoporosis, two with osteopenia and one patient had nor-
mal BMD values. The BMD values of the femoral neck of
each of the nine patients having undergone DEXA were
plotted against intraoperatively measured peak torque values
(see Fig. 6). As shown in the graph, there is some tendency
towards correlation of peak torque value and BMD.
Discussion
Despite the limited number of patients included in the pilot
study so far, the data presented clearly indicate that the
measurement principle and the DensiProbe® instrumenta-
tion are eligible for routine intraoperative use by trained
surgeons within the framework of a multicenter study. A
slight prolongation of the operating time as well as the
absence of any relevant complication that could be related
to the application of our measurement probe will assure
acceptance by the participating surgeons.
Figure 6 presents peak torque values measured with
DensiProbe® and BMD values measured by DEXA in the
same patients. These data have been included because they
outline a number of open questions that might be studied in
the future by means of the DensiProbe® method:
• Are we able to identify the cut-oV value for peak torque
when the application of advanced Wxation principles is
considered?
• What is the inXuence of an antiresorptive therapy on
bone strength?
The interpretation of possible correlations between these
data, however, has to be considered very carefully, because
BMD and peak torque analyze bone at two diVerent scales.
The concept of a material’s strength is well known from
material sciences. For a simple object composed of a uniform
material, a break occurs when the load applied creates a stress
that exceeds the strength of the material. But bone is a com-
plex composite material with a number of mechanical proper-
ties, and no single property adequately describes bone strength
[16]. Being aware of this limitation, the strength concept from
material sciences might also be applied to bone.
The major noninvasive measurement available for the
early diagnosis of osteoporosis is currently the measure-
ment of areal BMD by DEXA. Indeed, BMD is considered
a major determinant of bone strength from a macroscopic
point of view. Ex vivo studies performed on human mate-
rial have indicated an excellent correlation between BMD
of the proximal femur and bone strength as evaluated by
shear test of the femoral neck. BMD does not only integrate
the amount of mineral but also indirectly the dimension of
bone. BMD predicts approximately 66–74% of the varia-
tion in bone strength. BMD is a surrogate determinant of
bone strength to judge the overall status of a skeleton or of
a bone as a whole.
On the other hand, the knowledge of bone strength might
also help to isolate those patients at risk for loss of reduc-
tion, or penetration of a Wxation device as complications of
open reduction and internal Wxation. This information may
guide the surgeon in selecting the most appropriate fracture
Wxation device or technique: This may include hydroxyapa-
tite coated screws or pins which were demonstrated to
improve implant osteointegration in various animal [23–26]
studies and to enhance Wxation strength in osteoporotic
bone in randomized controlled clinical trials [27–29]. As an
alternative to the use of particular implants designed for
osteoporotic bone, the surgeon may consider to augment
Fig. 6 Intraoperative peak torque values plotted against BMD values
measured at the femoral neck123
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methacrylate bone cement according to our recently pub-
lished protocol [12]. This easy to apply technique has
shown to enhance implant anchorage in osteoporotic
cadaver femurs. The associated risk of embolism and clini-
cally relevant tissue necrosis may be lowered by the sug-
gested elution of fat and bone marrow prior to cement
application which allows smooth cement distribution in a
small volume around the screw tip [4, 30]. Besides these
techniques enhancing Wxation strength, the surgeon may
also decide on a more protective postoperative manage-
ment. In this context the concept of bone strength is applied
to the bone volume right next to the implant.
All terms describing bone strength can be derived from
the force-displacement diagram that results from a mechan-
ical test of loading a bone specimen until it breaks [16].
Laboratory studies have therefore been performed where
bone became subject of material testing [31, 32]. These test
principles can provide good information about bone
strength but can only be applied to small samples of bone
and are not available in routine clinical use. Nevertheless,
these studies form the basis for the idea to perform a simple
mechanical test in order to get better information about
bone strength.
This idea was Wrst followed in the Weld of spinal surgery.
Several groups have intended to predict pedicle screw loos-
ening or cut out by means of previous intraoperative
mechanical analysis of the bone [33–35]. These series have
shown uneven results. From our point of view, the pedicle
is not an ideal model to apply mechanical measurement of
bone strength. Whenever the probe comes into contact with
cortical bone, the mechanical competence is completely
diVerent from the trabecular bone. This means, the pre-
mises to apply a strength concept, e.g., the existence of a
homogeneous material is not valid.
We are going to evaluate our measurement principle
within the femoral head where we can be pretty sure, the
measurement probe does not get into contact with cortical
bone. This means, the premise to work with a “strength
concept” e.g., the existence of a “homogeneous material” is
fulWlled.
Within our stepwise approach to introduce the intraoper-
ative measurement of bone strength into clinical routine,
the next step will be a multicenter trial aiming to include
several hundreds of patients from diVerent hospitals.
Thereby, we may prove that the method can also be applied
securely and with reproducible results by such surgeons
who were not involved in the development of the concept
from the beginning.
Inclusion of suYcient patients to calculate the method’s
predictive value towards implant cut-out as a single risk
factor or in combination with other risk factors can only be
achieved by means of a multi center study. Further studies
investigating the mechanisms by which drugs reduce frac-
ture risk might also beneWt when intraoperative measure-
ment of bone strength by means of DensiProbe® becomes
available.
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